Veristat is proud to participate in the 2nd Annual Clinical Outsourcing Group CRO Summit, taking place December 2–3, 2025. This event will explore how CRO partnerships are redefining operational excellence, innovation, and flexibility across today’s evolving development landscape.
Sybil Wilson, Veristat’s Vice President of Global Commercial Operations, will moderate a high-profile CEO panel- Industry Predictions for 2026: Navigating the Future of Global Clinical Research. As the global clinical research landscape evolves, this session will explore how market dynamics, technological innovation, and regulatory developments are impacting trial designs, operational strategies, and competitive positioning. This panel brings together leading CRO executives sharing their perspectives on the opportunities and challenges ahead for CROs and their biopharma partners.
At Veristat, we deliver integrated operational flexibility and global collaboration to advance complex clinical programs—particularly in the most challenging therapeutic areas:
End-to end trial execution from first patient in to database lock
Vendor and site oversight that ensures quality and compliance
Adaptive trial designs that accelerate timelines
Global trial coordination with local regulatory insight
From early strategy through clinical trial conduct and regulatory submission, Veristat partners with sponsors to execute programs efficiently, compliantly, and with the flexibility today’s development environment demands.
Meet Us at the Show
Let’s connect at the CRO Summit to understand your needs and share how Veristat can help bring your novel therapies to life.